Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by prophetoffactzon Feb 23, 2023 5:09pm
77 Views
Post# 35302048

RE:RE:RE:RE:RE:RE:RE:RE:British Columbia Securities Commission!!

RE:RE:RE:RE:RE:RE:RE:RE:British Columbia Securities Commission!!narmac, ",,,all the contacts I have chatted with point to serious activity behind the scenes as I type......there is more than one group which finance public companies...&...there are numerous other business models to follow,,,,"

It's been over two weeks since narmac posted that. Midatech announced its financing three weeks ago. Will we see more than just a financing? Another attempt at a NASDAQ listing? That's where Ladenberg, Rathjen, and biotech money want stocks.
<< Previous
Bullboard Posts
Next >>